$Brucea javanica oil emulsion plus supportive care for refractory advanced colorectal cancer: a pilot RCT protocol$

Brucea javanica oil emulsion plus supportive care for refractory advanced colorectal cancer: a pilot RCT protocol

BackgroundColorectal cancer (CRC) is a significant contributor to global mortality. However, the existing therapeutic approaches often fall short of achieving favorable outcomes especially in metastatic CRC. Brucea javanica Oil Emulsion Injection (BJOEI) as adjuvant therapy also showed superiority f...

Full description

Saved in:

Bibliographic Details
Main Authors:	Liyuan Fang, Yan Wang, Yuhang Fang, Runxi Wang, Yi Xie, Shuhan Yang, Suying Liu, Ying Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Pharmacology
Subjects:	colorectal cancer Chinese herbal medicine randomized controlled trial BJOEI progression-free survival
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1610575/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Therapeutic Effect of Brucea Javanica Oil Emulsion in Mice with Irinotecan-Induced Delayed Diarrhea
by: Lai Z, et al.
Published: (2025-06-01)

Evaluation of Antidiabetic and Antioxidant Properties of Brucea javanica Seed
by: Abdulwali Ablat, et al.
Published: (2014-01-01)

Mechanism of Brucea javanica against multiple myeloma via TNF-NF-κB signaling
by: Yuan Wang, et al.
Published: (2025-07-01)

Mechanisms Underlying the Therapeutic Effects of Brucea javanica in Cervical Cancer Treatment Based on Network Pharmacology and Molecular Docking
by: Wen Jin, et al.
Published: (2025-01-01)

The mechanisms of Brucea javanica in the treatment of oral squamous cell carcinoma: a network pharmacology, molecular docking, and experimental study
by: MingKang Li, et al.
Published: (2025-06-01)

Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy
by: Bożena Cybulska-Stopa, et al.
Published: (2020-03-01)

Combination of Compound Kushen injection with first-line treatment versus first-line treatment alone for advanced colorectal cancer: a study protocol for a multicenter, openlabel, randomized controlled trial
by: Jingyuan Wu, et al.
Published: (2024-12-01)

Natural Product Bruceine A from Brucea javanica(L.) Merr. as a Potential LDLR Inhibitor That Facilitates Antiviral Effect
by: Kaiyue Zuo, et al.
Published: (2025-06-01)

Dynamics of the immune microenvironment and immune cell PANoptosis in colorectal cancer: recent advances and insights
by: Jinlong Wan, et al.
Published: (2024-11-01)

Growth Inhibition and Additive Effect to Antimalarial Drugs of <i>Brucea javanica</i> Extracts on Asexual Blood-Stage <i>Plasmodium falciparum</i>
by: Niwat Kangwanrangsan, et al.
Published: (2025-06-01)

Prognostic role of preoperative inflammatory markers in postoperative lung metastasis of colorectal cancer: a retrospective study
by: Jiukang Sun, et al.
Published: (2025-07-01)

Fecal galectin-1 as a potential marker for colorectal cancer and disease severity
by: Jovanović Milan, et al.
Published: (2019-01-01)

SATB1 mediated tumor colonization and β-catenin nuclear localization are associated with colorectal cancer progression
by: Luan Sun, et al.
Published: (2024-12-01)

Mechanism of Astragaloside-Brucea javanica oil nanoemulsion against oral squamous cell carcinoma through CDK1/MTFR2: Network pharmacology, bioinformatics, and experimental studies.
by: Yihan Lai, et al.
Published: (2025-01-01)

Outcomes of ultrasound-guided percutaneous ablation of >5 versus ≤ 5 colorectal liver metastases: a propensity score matching study
by: Jingwen Zhou, et al.
Published: (2025-12-01)

A New Chapter in Colorectal Cancer Treatment: Insights from 2024 ASCO Annual Meeting
by: Miaomiao GOU, et al.
Published: (2024-12-01)

Eucalyptus (Eucalyptus camaldulensis) and chinaberry (Melia azedarach) extracts' potential for sustainable control of root-knot nematode, Meloidogyne javanica
by: Salma sadat Torabi, et al.
Published: (2024-12-01)

TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis
by: Ritam Joarder, et al.

Study on prediction model and influencing factors of progression-free survival in colorectal cancer
by: CHEN Jiaying, et al.
Published: (2025-03-01)

Progress on the mechanism of intestinal microbiota against colorectal cancer
by: Guoqiang Xing, et al.
Published: (2025-04-01)

Identification of progression related LncRNAs in colorectal cancer aggressiveness
by: Wei Xi, et al.
Published: (2025-05-01)

Wnt5a suppresses colorectal cancer progression via TGF-β/NOTUM/OLFM4 axis in patient-derived organoids
by: Yewei Huang, et al.
Published: (2025-08-01)

Next Generation of Colorectal Cancer Management: Integrating Omics, Targeted Therapies, and Smart Technologies
by: Tamer A. Addissouky
Published: (2024-12-01)

The potential clinical value of platelet aggregation in colorectal tumor progression
by: Yuyu Chen, et al.
Published: (2024-11-01)

Predictive value of inflammatory regulators TGFb1 and CXCL8 in tumor tissue in colorectal cancer
by: I. A. Bogomolova, et al.
Published: (2023-04-01)

Prolonged Survival Outcome in a Patient with Refractory Metastatic Colorectal Cancer Treated with Regorafenib Plus 5-Fluorouracil: A Case Report and Literature Review
by: Abdullah Esmail, et al.
Published: (2025-04-01)

Aberrant DNMT1-mediated DACH1 methylation is associated with colorectal adenoma-to-carcinoma progression
by: Yan Zhang, et al.
Published: (2025-04-01)

Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer
by: Maria Ignez Freitas Melro Braghiroli, et al.
Published: (2024-01-01)

Characteristics of local and system immunity, and features of cancer stem cells in patients with different stage, dynamics and prognosis of colorectal carcinoma
by: E. Yu. Zlatnik, et al.
Published: (2022-03-01)

Real world effectiveness of chemotherapy plus bevacizumab with immunotherapy in colorectal cancer
by: Zhao Gao, et al.
Published: (2025-08-01)

The association between neutrophil percentage to albumin ratio and progression-free survival and overall survival in colorectal cancer patients: a retrospective cohort study
by: Hailun Xie, et al.
Published: (2025-07-01)

Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients
by: Toshiaki Takahashi, et al.
Published: (2025-01-01)

Upregulation of RIG‐I is Critical for Responsiveness to IFN‐α Plus Anti‐PD‐1 in Colorectal Cancer
by: Haihang Nie, et al.
Published: (2025-03-01)

MiRNA expression affects survival in patients with obstructive sleep apnea and metastatic colorectal cancer
by: Piera Soccio, et al.
Published: (2025-02-01)

Real-World Comparison of Trifluridine–Tipiracil with or Without Bevacizumab in Patients with Refractory Metastatic Colorectal Cancer
by: Hyunho Kim, et al.
Published: (2025-04-01)

Colorectal cancer progression to metastasis is associated with dynamic genome-wide biphasic 5-hydroxymethylcytosine accumulation
by: Ben Murcott, et al.
Published: (2025-04-01)

The impact of combining cetuximab with the traditional chemotherapy regimens on clinical effectiveness in metastatic colorectal cancer: a systematic review and meta-analysis
by: Marryam Azeem, et al.
Published: (2025-02-01)

Effects of Chinese herbal medicine on colorectal adenoma recurrence following polypectomy: a systematic review and meta-analysis
by: Yi Cheng, et al.
Published: (2025-03-01)

Cetuximab plus XELOX show efficacy against brain metastasis from colorectal cancer: a case report
by: Ahmad KH Ibrahimi, et al.
Published: (2023-06-01)

[Comment] Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): a randomized controlled trial
by: Zhang Rongxin
Published: (2024-08-01)